Walters, M., Wang, Y., Lai, N., Baumgart, T., Zhao, B., Dairaghi, D., . . . Schall, T. (2010). Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
Čikaški stil citiranja (17. izdanje)Walters, M., et al. Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease. 2010.
MLA način citiranja (9. izdanje)Walters, M., et al. Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease. 2010.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.